The toxic effect of cytostatics on primary cilia frequency and multiciliation
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
31207084
PubMed Central
PMC6652919
DOI
10.1111/jcmm.14487
Knihovny.cz E-resources
- Keywords
- doxorubicin, multiple cilia, primary cilium, triple-negative breast cancer,
- MeSH
- Cilia drug effects metabolism MeSH
- Cytostatic Agents toxicity MeSH
- Doxorubicin pharmacology MeSH
- Fibroblasts drug effects metabolism MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Paclitaxel pharmacology MeSH
- Cell Proliferation drug effects MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cytostatic Agents MeSH
- Doxorubicin MeSH
- Paclitaxel MeSH
The primary cilium is considered as a key component of morphological cellular stability. However, cancer cells are notorious for lacking primary cilia in most cases, depending upon the tumour type. Previous reports have shown the effect of starvation and cytostatics on ciliogenesis in normal and cancer cells although with limited success, especially when concerning the latter. In this study, we evaluated the presence and frequency of primary cilia in breast fibroblasts and in triple-negative breast cancer cells after treatment with cytostatics finding that, in the case of breast fibroblasts, primary cilia were detected at their highest incidence 72 hours after treatment with 120 nM doxorubicin. Further, multiciliated cells were also detected after treatment with 80 nM doxorubicin. On the other hand, treatment with taxol increased the number of ciliated cells only at low concentrations (1.25 and 3.25 nM) and did not induce multiciliation. Interestingly, triple-negative breast cancer cells did not present primary cilia after treatment with either doxorubicin or taxol. This is the first study reporting the presence of multiple primary cilia in breast fibroblasts induced by doxorubicin. However, the null effect of these cytostatics on primary cilia incidence in the evaluated triple negative breast carcinomas cell lines requires further research.
Department of Biomedical Sciences Faculty of Health Sciences University of Hull Hull UK
Department of Oncology Thomayer Hospital Charles University Prague Czech Republic
See more in PubMed
Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1‐dependent Aurora A activation induces disassembly of the primary cilium. Cell. 2007;129:1351‐1363. PubMed PMC
Li A, Saito M, Chuang J‐Z, et al. Ciliary transition zone activation of phosphorylated Tctex‐1 controls ciliary resorption, S‐phase entry and fate of neural progenitors. Nat Cell Biol. 2011;13:402‐411. PubMed PMC
Spalluto C, Wilson DI, Hearn T. Evidence for reciliation of RPE1 cells in late G1 phase, and ciliary localisation of cyclin B1. FEBS Open Bio. 2013;3:334‐340. PubMed PMC
Luesma MJ, Cantarero I, Castiella T, Soriano M, Garcia‐Verdugo JM, Junquera C. Enteric neurons show a primary cilium. J. Cell. Mol. Med. 2013;17:147‐153. PubMed PMC
Malone A, Anderson CT, Tummala P, et al. Primary cilia mediate mechanosensing in bone cells by a calcium‐independent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2007;104:13325‐13330. PubMed PMC
Nigg EA. Origins and consequences of centrosome aberrations in human cancers. Int. J. Cancer. 2006;119:2717‐2723. PubMed
Nigg EA, Čajánek L, Arquint C. The centrosome duplication cycle in health and disease. FEBS Lett. 2014;588:2366‐2372. PubMed
Conroy PC, Saladino C, Dantas TJ, Lalor P, Dockery P, Morrison CG. C‐NAP1 and rootletin restrain DNA damage‐induced centriole splitting and facilitate ciliogenesis. Cell Cycle. 2012;11:3769‐3778. PubMed PMC
Filipová A, Diaz‐Garcia D, Bezrouk A, et al. Ionizing radiation increases primary cilia incidence and induces multiciliation in C2C12 myoblasts: Induction of primary cilia by irradiation. Cell Biol Int. 2015;39:943‐953. PubMed
Lee K, Battini L, Gusella GL. Cilium, centrosome and cell cycle regulation in polycystic kidney disease. Biochim. Biophys. Acta. 2011;1812:1263‐1271. PubMed PMC
Yuan K, Frolova N, Xie YI, et al. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues. J. Histochem. Cytochem. 2010;58:857‐870. PubMed PMC
Habib JG, O’Shaughnessy JA. The hedgehog pathway in triple‐negative breast cancer. Cancer Med. 2016;5:2989‐3006. PubMed PMC
Dubuc C, Savard M, Bovenzi V, et al. Targeting intracellular B2 receptors using novel cell‐penetrating antagonists to arrest growth and induce apoptosis in human triple‐negative breast cancer. Oncotarget. 2018;9:9885‐9906. PubMed PMC
Hofman J, Skarka A, Havrankova J, Wsol V. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases. Biochem Pharmacol. 2015;96:168‐178. PubMed
Sharma N, Kosan ZA, Stallworth JE, Berbari NF, Yoder BK. Soluble levels of cytosolic tubulin regulate ciliary length control. Mol. Biol. Cell. 2011;22:806‐816. PubMed PMC
Bershteyn M, Atwood SX, Woo W‐M, Li M, Oro AE. MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Dev Cell. 2010;19:270‐283. PubMed PMC
Kim J, Lee JE, Heynen‐Genel S, et al. Functional genomic screen for modulators of ciliogenesis and cilium length. Nature. 2010;464:1048‐1051. PubMed PMC
Goranci‐Buzhala G, Gabriel E, Mariappan A, Gopalakrishnan J. Losers of primary cilia gain the benefit of survival. Cancer Discov. 2017;7:1374‐1375. PubMed
Stinchcombe JC, Salio M, Cerundolo V, Pende D, Arico M, Griffiths GM. Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems. BMC Biol. 2011;9:45. PubMed PMC
Dvořák J, Sitorová V, Nikolov HD, et al. Primární řasinky a jejich biologické funkce. Onkologie. 2011;5:234‐238.
Liu A, Wang B, Niswander LA. Mouse intraflagellar transport proteins regulate both the activator and repressor functions of Gli transcription factors. Development. 2005;132:3103‐3111. PubMed
Gerhardt C, Leu T, Lier JM, Rüther U. The cilia‐regulated proteasome and its role in the development of ciliopathies and cancer. Cilia. 2016;5:14. PubMed PMC
Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Low concentrations of paclitaxel induce cell type‐dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel‐induced cytotoxicity. Oncogene. 2001;20:3806‐3813. PubMed
Menzl I, Lebeau L, Pandey R, et al. Loss of primary cilia occurs early in breast cancer development. Cilia. 2014;3:7. PubMed PMC
Hassounah NB, Nunez M, Fordyce C, et al. Inhibition of ciliogenesis promotes hedgehog signaling, tumorigenesis, and metastasis in breast cancer. Mol. Cancer Res. 2017;15:1421‐1430. PubMed PMC
Alli E, Yang J‐M, Hait WN. Silencing of stathmin induces tumor‐suppressor function in breast cancer cell lines harboring mutant p53. Oncogene. 2007;26:1003‐1012. PubMed
Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal Centrosome Amplification in the Absence of p53. Science. 1996;271:1744‐1747. PubMed
Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat. Rev. Cancer. 2002;2:815‐825. PubMed
Tutt A, Gabriel A, Bertwistle D, et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 1999;9:1107‐1110. PubMed
Mahjoub MR, Stearns T. Supernumerary centrosomes nucleate extra cilia and compromise primary cilium signaling. Curr. Biol. 2012;22:1628‐1634. PubMed PMC
Lancaster MA, Schroth J, Gleeson JG. Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat. Cell Biol. 2011;13:700‐707. PubMed PMC
Plotnikova OV, Pugacheva EN, Golemis EA. Primary cilia and the cell cycle. Methods Cell Biol. 2009;94:137‐160. PubMed PMC
Nobutani K, Shimono Y, Yoshida M, et al. Absence of primary cilia in cell cycle‐arrested human breast cancer cells. Genes Cells. 2014;19:141‐152. PubMed